Skip to main content
Premium Trial:

Request an Annual Quote

Patrick Daugherty

The American Chemical Society this week announced that Patrick Daugherty, an assistant professor of chemical engineering at the University of California, Santa Barbara, has won its Young Investigator Award. The award, which includes a $3,000 prize, is sponsored by Genentech.
The Society said it recognized Daugherty for his “outstanding contributions to the field of protein engineering, including the development of novel peptide display methodologies, fluorescent protein sensors, and library screening methodologies.”
Daugherty will deliver the Biochemical Technology Young Investigator Award Lecture at the ACS meeting in Boston in August. His research interests focus on developing and applying methods to diagnose and treat disease by applying emerging biotechnologies to molecular and cellular engineering.
Daugherty completed a postdoctoral fellowship at the Fred Hutchinson Cancer Research Center in Seattle, Wash, after receiving his PhD at the University of Texas at Austin.
Daugherty previously received the Camille Dreyfus Teacher Scholar Award, a National Science Foundation Career Award, and the Santa Barbara Cottage Hospital Research Award.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.